Publications powered by Harvard Catalyst Profiles

1. Multimodal imaging of spike propagation: a technical case report. AJNR Am J Neuroradiol. 2012 Jun; 33(6):E82-4. View abstract
2. Rufinamide for the treatment of epileptic spasms. Epilepsy Behav. 2011 Feb; 20(2):344-8. View abstract
3. Higher evening antiepileptic drug dose for nocturnal and early-morning seizures. Epilepsy Behav. 2011 Feb; 20(2):334-7. View abstract
4. Nocturnal choking episodes: under-recognized and misdiagnosed. Pediatr Neurol. 2010 Nov; 43(5):355-8. View abstract
5. Experience with rufinamide in a pediatric population: a single center's experience. Pediatr Neurol. 2010 Sep; 43(3):155-8. View abstract
6. Clinical reasoning: a teenage girl with excessive daytime sleepiness, "fainting spells," and dream mentations. Neurology. 2010 May 25; 74(21):e88-92. View abstract
7. "The choking game": self-induced hypoxia presenting as recurrent seizurelike events. Epilepsy Behav. 2008 Apr; 12(3):486-8. View abstract
8. Oxcarbazepine in children with nocturnal frontal-lobe epilepsy. Pediatr Neurol. 2007 Nov; 37(5):345-9. View abstract
9. Electroencephalography in neonatal seizures: comparison of a reduced and a full 10/20 montage. Pediatr Neurol. 2005 Mar; 32(3):155-61. View abstract
10. Normal Pediatric EEG. The Clinical Neurophysiology Primer. Eds Blum A, Rutkove S. In press. 2005. View abstract
11. Neonatal Seizures. Treatment of Pediatric Neurologic Disorders. Eds Singer HS, Kossoff E, Hartman A. In press. 2005. View abstract
12. EEG in neonatal seizures: comparison of a reduced and a full 10/20 montage. In press. Journal of Child Neurology. 2005. View abstract
13. Pharyngeal dysesthesia in refractory complex partial epilepsy: new seizure or adverse effect of vagal nerve stimulation? Epilepsia. 2003 Jun; 44(6):855-8. View abstract
14. Pharmacotherapy of paediatric epilepsy. Expert Opin Pharmacother. 2003 Apr; 4(4):421-31. View abstract
15. New antiepileptic drug therapies. Neurol Clin. 2002 Nov; 20(4):1163-82. View abstract
16. Recurrent hypoglycemic hemiparesis and aphasia in an adolescent patient. Pediatr Neurol. 2001 May; 24(5):385-6. View abstract
17. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology. 2001 Feb 13; 56(3):411-2. View abstract
18. Relaxation therapy in Tourette syndrome: a pilot study. Pediatr Neurol. 1998 Feb; 18(2):136-42. View abstract
19. Cerebrospinal fluid free choline in movement disorders of paediatric onset. Eur J Paediatr Neurol. 1998; 2(1):33-9. View abstract
20. Identification and characterization of a mouse homologue of the spinal muscular atrophy-determining gene, survival motor neuron. Gene. 1997 Dec 19; 204(1-2):47-53. View abstract
21. MR findings in adult-onset adrenoleukodystrophy. AJNR Am J Neuroradiol. 1995 Jun-Jul; 16(6):1227-37. View abstract
22. Adrenoleukodystrophy: phenotypic variability and implications for therapy. J Inherit Metab Dis. 1992; 15(4):645-64. View abstract
23. Peroxisomal disorders. Biochem Cell Biol. 1991 Jul; 69(7):463-74. View abstract
24. Adrenoleukodystrophy. Endocrinol Metab Clin North Am. 1991 Jun; 20(2):297-318. View abstract
25. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci. 1991; 13(4-5):254-61. View abstract
26. Problems with pancuronium in the neonatal intensive care unit. Ir Med J. 1988 Nov; 81(1):39-40. View abstract
27. Trisomy 18: a nine year review. Ir J Med Sci. 1988 Jan; 157(1):5-7. View abstract
28. Cardiac constriction due to malignant disease of the pericardium. Ir J Med Sci. 1983 Dec; 152(12):454-5. View abstract
29. Valve replacement for aortic valve disease. Ir Med J. 1983 Aug; 76(8):338-40. View abstract
30. The value of radioimmunoassay of parathyroid hormone in diagnosis of hyperparathyroidism, renal calculi, hypercalcaemia and metabolic bone disease. Ir Med J. 1981 Feb; 74(2):59-62. View abstract